• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Ischemia (1942); Restenosis (4576)
Event Date 04/12/2023
Event Type  Injury  
Event Description
Agent ide study.On an unspecified date, 3.00mm x 38mm and 3.00mm x 28mm promus elite stents were implanted in the mid right coronary artery (rca).On (b)(6) 2023, pet stress test revealed moderate inferoapical and inferolateral ischemia.The subject was recommended for coronary angiography to access stent patency and detect scarring/ in-stent restenosis.On (b)(6) 2023, ecg revealed sinus bradycardia with 1st degree a-v block.On (b)(6) 2023, the subject presented to hospital for planned diagnostic coronary angiography and was noted to have chest pain and fatigue as ongoing symptoms.The subject was hospitalized on the same day and underwent diagnostic coronary angiography which revealed 50% in-stent restenosis at mid segment rca associated with ischemia and abnormal ecg.The subject was diagnosed with class 2 symptoms and moderate ischemia.On (b)(6) 2023, the 95% stenosed obtuse marginal was treated with a 2.50 x 20mm promus elite stent resulting in residual stenosis of less than 10% and timi flow of 3.The event was considered resolved and the subject was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELITE
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key17288056
MDR Text Key318676944
Report Number2124215-2023-34612
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/15/2023
Initial Date FDA Received07/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age77 YR
Patient SexMale
Patient RaceWhite
-
-